RSS-Feed abonnieren
DOI: 10.1055/a-2413-3171
Evaluation of an Outpatient Cervical Ripening Program Using Osmotic Dilators and Foley Balloon Catheters
Funding This study was supported by the Allina Health Foundation (grant no.: 21-0053).
Abstract
Objective
This study aimed to describe patient characteristics, satisfaction, and outcome measures for patients undergoing outpatient cervical ripening.
Study Design
A retrospective cohort study using electronic health record data from March 2020 to March 2022 from a large health system. The sample included patients with a low-risk singleton pregnancy undergoing outpatient cervical ripening with either an osmotic dilator or Foley balloon catheter. A subset of patients completed satisfaction surveys. Frequencies and means were used to describe the population and conduct comparisons by device type. Inverse probability of treatment weighted estimates were generated to address baseline differences between patients in the two device groups.
Results
Outpatient cervical ripening was completed by 120 patients (80 osmotic dilators and 40 Foley balloon catheters). The mean time from insertion to inpatient admission was 16.2 ± 4.8 hours. The mean change in simplified Bishop score (SBS) was 1.8 ± 1.4 and the mean change in dilation was 1.8 ± 1.1 cm. There were no differences in the amount of cervical change by device type. Patients returned earlier than planned 16.7% of the time, primarily for contractions or rupture of membranes. Following outpatient cervical ripening, the time from admission to delivery was 19.9 ± 10.3 hours, with no difference by device type. Vaginal delivery occurred for 74.8% of patients. Patients reported overall satisfaction with the outpatient cervical ripening experience, with the highest satisfaction among those with osmotic dilators. Patients with both device types stated they would recommend outpatient cervical ripening to others, and experienced low levels of stress and discomfort at home prior to hospital admission.
Conclusion
Patients participating in outpatient cervical ripening with osmotic dilators or Foley balloon catheters experienced clinically meaningful changes in dilation and SBSs while at home and reported general satisfaction with the outpatient program experience.
Key Points
-
Outpatient use of osmotic dilators or Foley balloon catheters improved Bishop scores.
-
Patient and device complications were comparable to other research findings.
-
Patients reported overall satisfaction with outpatient cervical ripening.
Publikationsverlauf
Eingereicht: 07. Mai 2024
Angenommen: 11. September 2024
Artikel online veröffentlicht:
10. Oktober 2024
© 2024. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Martin JA, Hamilton BE, Osterman MJ, Driscoll AK, Births PD. Final data for 2017 National Vital Statistics Reports: from the Centers for Disease Control and Prevention, National Center for Health Statistics. Natl Vital Stat Sys 2018; 67: 1-50
- 2 Bernardes TP, Broekhuijsen K, Koopmans CM. et al. Caesarean section rates and adverse neonatal outcomes after induction of labour versus expectant management in women with an unripe cervix: a secondary analysis of the HYPITAT and DIGITAT trials. BJOG 2016; 123 (09) 1501-1508
- 3 Grobman WA, Rice MM, Reddy UM. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal–Fetal Medicine Units Network. Labor induction versus expectant management in low-risk nulliparous women. N Engl J Med 2018; 379 (06) 513-523
- 4 Grobman WACA, Caughey AB. Elective induction of labor at 39 weeks compared with expectant management: a meta-analysis of cohort studies. Am J Obstet Gynecol 2019; 221 (04) 304-310
- 5 Walker KFBG, Bugg GJ, Macpherson M. et al; 35/39 Trial Group. Randomized trial of labor induction in women 35 years of age or older. N Engl J Med 2016; 374 (09) 813-822
- 6 Amorosa JM, Stone JL. Outpatient cervical ripening. Semin Perinatol 2015; 39 (06) 488-494
- 7 Wilkinson C, Bryce R, Adelson P, Turnbull D. A randomised controlled trial of outpatient compared with inpatient cervical ripening with prostaglandin E2 (OPRA study). BJOG 2015; 122 (01) 94-104
- 8 Leopold B, Sciscione A. Is there a place for outpatient preinduction cervical ripening?. Obstet Gynecol Clin North Am 2017; 44 (04) 583-591
- 9 Wang MJJV, George DM, Kuper SG. et al. Patient satisfaction with outpatient cervical ripening in parous women. Am J Perinatol 2020; 38: e71-e76
- 10 Chen V, Sheehan P. Outpatient management of pre-induction cervical ripening. J Matern Fetal Neonatal Med 2022; 35 (15) 2954-2960
- 11 Policiano C, Pimenta M, Martins D, Clode N. Outpatient versus inpatient cervix priming with Foley catheter: a randomized trial. Eur J Obstet Gynecol Reprod Biol 2017; 210: 1-6
- 12 Son SLBA, Benson AE, Hart Hayes E, Subramaniam A, Clark EAS, Einerson BD. Outpatient cervical ripening: a cost-minimization and threshold analysis. Am J Perinatol 2020; 37 (03) 245-251
- 13 Sciscione AC, Muench M, Pollock M, Jenkins TM, Tildon-Burton J, Colmorgen GH. Transcervical Foley catheter for preinduction cervical ripening in an outpatient versus inpatient setting. Obstet Gynecol 2001; 98 (5 Pt 1): 751-756
- 14 Sciscione ACBC, Bedder CL, Hoffman MK, Ruhstaller K, Shlossman PA. The timing of adverse events with Foley catheter preinduction cervical ripening; implications for outpatient use. Am J Perinatol 2014; 31 (09) 781-786
- 15 Beckmann M, Gibbons K, Flenady V, Kumar S. Induction of labour using prostaglandin E2 as an inpatient versus balloon catheter as an outpatient: a multicentre randomised controlled trial. BJOG 2020; 127 (05) 571-579
- 16 Crosby DA, O'Reilly C, McHale H, McAuliffe FM, Mahony R. A prospective pilot study of Dilapan-S compared with Propess for induction of labour at 41+ weeks in nulliparous pregnancy. Ir J Med Sci 2018; 187 (03) 693-699
- 17 Gupta J, Chodankar R, Baev O. et al. Synthetic osmotic dilators in the induction of labour-An international multicentre observational study. Eur J Obstet Gynecol Reprod Biol 2018; 229: 70-75
- 18 Maier JT, Metz M, Watermann N. et al. Induction of labor in patients with an unfavorable cervix after a cesarean using an osmotic dilator versus vaginal prostaglandin. J Perinat Med 2018; 46 (03) 299-307
- 19 Maier JT, Schalinski E, Gauger U, Hellmeyer L. Cervical ripening with an Osmotic DIlator (Dilapan-S) in term pregnancies - an observational study. J Gynecol Neonatal Biol 2015; 1 (03) 1-6
- 20 Saad AFVJ, Villarreal J, Eid J. et al. A randomized controlled trial of Dilapan-S vs Foley balloon for preinduction cervical ripening (DILAFOL trial). Am J Obstet Gynecol 2019; 220 (03) 275.e1-275.e9
- 21 Shindo R, Aoki S, Yonemoto N. et al. Hygroscopic dilators vs balloon catheter ripening of the cervix for induction of labor in nulliparous women at term: Retrospective study. PLoS ONE 2017; 12 (12) e0189665
- 22 Saad AF, Gavara R, Senguttuvan RN. et al. Outpatient compared with inpatient preinduction cervical ripening using a synthetic osmotic dilator: a randomized clinical trial. Obstet Gynecol 2022; 140 (04) 584-590
- 23 Kummer J, Koenigbauer JT, Callister Y. et al. Cervical ripening as an outpatient procedure in the pandemic - minimizing the inpatient days and lowering the socioeconomic costs. J Perinat Med 2022; 50 (09) 1180-1188
- 24 Vogel JPOA, Osoti AO, Kelly AJ, Livio S, Norman JE, Alfirevic Z. Pharmacological and mechanical interventions for labour induction in outpatient settings. Cochrane Database Syst Rev 2017; 9 (09) CD007701
- 25 Sangskär H, Berglin L, Sengpiel V. et al. Safety, effectiveness, women's experience, and economic costs of outpatient induction in women with uncomplicated pregnancies: a systematic review and meta-analyses. Int J Gynaecol Obstet 2022; 161: 343-355
- 26 Laughon SK, Zhang J, Troendle J, Sun L, Reddy UM. Using a simplified Bishop score to predict vaginal delivery. Obstet Gynecol 2011; 117 (04) 805-811
- 27 Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med 2015; 34 (28) 3661-3679
- 28 Fagerland MW, Lydersen S, Laake P. Recommended confidence intervals for two independent binomial proportions. Stat Methods Med Res 2015; 24 (02) 224-254
- 29 Pierce-Williams R, Lesser H, Saccone G. et al. Outpatient cervical ripening with balloon catheters: a systematic review and meta-analysis. Obstet Gynecol 2022; 139 (02) 255-268
- 30 Washburn MC, Washburn M, Hong C, Roth P, Richter P. Outpatient Foley catheter induction protocol provides clinical and cost benefits. Birth 2021; 48 (04) 574-582
- 31 Blair R, Harvey MA, Pudwell J, Bougie O. Retrospective comparison of PGE2 vaginal insert and foley catheter for outpatient cervical ripening. J Obstet Gynaecol Can 2020; 42 (09) 1103-1110
- 32 Bhide A, Sedgwick P, Barrett B. et al. Prostaglandin insert dinoprostone versus trans-cervical balloon catheter for outpatient labour induction: a randomised controlled trial of feasibility (PROBIT-F). Pilot Feasibility Stud 2020; 6: 113
- 33 Biem Sr. SR, Turnell RW, Olatunbosun O, Tauh M, Biem HJ. A randomized controlled trial of outpatient versus inpatient labour induction with vaginal controlled-release prostaglandin-E2: effectiveness and satisfaction. J Obstet Gynaecol Can 2003; 25 (01) 23-31
- 34 McDonagh M, Skelly AC, Tilden E. et al. Outpatient cervical ripening: a systematic review and meta-analysis. Obstet Gynecol 2021; 137 (06) 1091-1101
- 35 Ausbeck EB, Jauk VC, Xue Y. et al. Outpatient Foley catheter for induction of labor in nulliparous women: a randomized controlled trial. Obstet Gynecol 2020; 136 (03) 597-606